{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:20:15Z","timestamp":1783002015121,"version":"3.54.5"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1093\/jnci\/dju300","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T03:42:44Z","timestamp":1412912564000},"source":"Crossref","is-referenced-by-count":38,"title":["Use of Appropriate Initial Treatment Among Adolescents and Young Adults With Cancer"],"prefix":"10.1093","volume":"106","author":[{"given":"Arnold L.","family":"Potosky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda C.","family":"Harlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Albritton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary D.","family":"Cress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa H.M.","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Keel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita L.","family":"Seibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarett","family":"Shnorhavorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"key":"key\n\t\t\t\t20170520213912_CIT0001","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/cncr.22102","article-title":"Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials","volume":"107","author":"Bleyer","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"key\n\t\t\t\t20170520213912_CIT0002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3322\/canjclin.57.4.242","article-title":"Young adult oncology: the patients and their survival challenges","volume":"57","author":"Bleyer","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"key\n\t\t\t\t20170520213912_CIT0003","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.6004\/jnccn.2012.0112","article-title":"How NCCN guidelines can help young adults and older adolescents with cancer and the professionals who care for them","volume":"10","author":"Bleyer","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"32","key":"key\n\t\t\t\t20170520213912_CIT0004","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1200\/JCO.2010.30.5128","article-title":"Adolescent and young adult oncology: An emerging field","volume":"28","author":"Thomas","year":"2010","journal-title":"J Clin Oncol"},{"issue":"18","key":"key\n\t\t\t\t20170520213912_CIT0005","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.ejca.2003.09.013","article-title":"The management of cancer in the older adolescent","volume":"39","author":"Albritton","year":"2003","journal-title":"Eur J Cancer"},{"issue":"5","key":"key\n\t\t\t\t20170520213912_CIT0006","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/08880010701316850","article-title":"Adolescent and young adult (AYA) oncology: the first A","volume":"24","author":"Bleyer","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t20170520213912_CIT0007","author":"Albritton","year":"2006"},{"issue":"5","key":"key\n\t\t\t\t20170520213912_CIT0008","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.seminoncol.2009.07.009","article-title":"Lymphoma in adolescents and young adults","volume":"36","author":"Jaglowski","year":"2009","journal-title":"Semin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20170520213912_CIT0009","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrc2349","article-title":"The distinctive biology of cancer in adolescents and young adults","volume":"8","author":"Bleyer","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"key\n\t\t\t\t20170520213912_CIT0010","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ctrv.2006.11.005","article-title":"Participation of adolescents with cancer in clinical trials","volume":"33","author":"Ferrari","year":"2007","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"key\n\t\t\t\t20170520213912_CIT0011","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.seminoncol.2009.03.002","article-title":"The unique characteristics of ovarian carcinogenesis in the adolescent and young adult population","volume":"36","author":"Gibbon","year":"2009","journal-title":"Semin Oncol"},{"issue":"11","key":"key\n\t\t\t\t20170520213912_CIT0012","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/cncr.23060","article-title":"Challenges in the recruitment of adolescents and young adults to cancer clinical trials","volume":"110","author":"Burke","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170520213912_CIT0013","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/cncr.22104","article-title":"Proceedings of a workshop: bridging the gap in care and addressing participation in clinical trials","volume":"107","author":"Bleyer","year":"2006","journal-title":"Cancer"},{"issue":"11","key":"key\n\t\t\t\t20170520213912_CIT0014","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/cncr.23060","article-title":"Challenges in the recruitment of adolescents and young adults to cancer clinical trials","volume":"110","author":"Burke","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"key\n\t\t\t\t20170520213912_CIT0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11764-011-0173-y","article-title":"Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study","volume":"5","author":"Harlan","year":"2011","journal-title":"J Cancer Surviv"},{"issue":"7001","key":"key\n\t\t\t\t20170520213912_CIT0016","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"issue":"31","key":"key\n\t\t\t\t20170520213912_CIT0017","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children\u2019s oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170520213912_CIT0018","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2007-02-070342","article-title":"Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"111","author":"Seibel","year":"2008","journal-title":"Blood"},{"issue":"7","key":"key\n\t\t\t\t20170520213912_CIT0019","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"issue":"12","key":"key\n\t\t\t\t20170520213912_CIT0020","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"issue":"12","key":"key\n\t\t\t\t20170520213912_CIT0021","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","article-title":"Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate","volume":"103","author":"Thomas","year":"2004","journal-title":"Blood"},{"issue":"8","key":"key\n\t\t\t\t20170520213912_CIT0022","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","article-title":"A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811","volume":"85","author":"Larson","year":"1995","journal-title":"Blood"},{"issue":"5","key":"key\n\t\t\t\t20170520213912_CIT0023","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2008-01-130237","article-title":"What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children\u2019s Cancer Group and Cancer and Leukemia Group B studies","volume":"112","author":"Stock","year":"2008","journal-title":"Blood"},{"issue":"10","key":"key\n\t\t\t\t20170520213912_CIT0024","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2008-10-184143","article-title":"A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425","volume":"114","author":"Schwartz","year":"2009","journal-title":"Blood"},{"issue":"3","key":"key\n\t\t\t\t20170520213912_CIT0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2006.0024","article-title":"Late effects of treatment for Hodgkin lymphoma","volume":"4","author":"Friedman","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"key\n\t\t\t\t20170520213912_CIT0026","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2008.04.067","article-title":"Subsequent malignancies in children treated for Hodgkin\u2019s disease: associations with gender and radiation dose","volume":"72","author":"Constine","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"key\n\t\t\t\t20170520213912_CIT0027","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2010-05-285379","article-title":"BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children\u2019s Oncology Group","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"issue":"10","key":"key\n\t\t\t\t20170520213912_CIT0028","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2008-10-184143","article-title":"A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425","volume":"114","author":"Schwartz","year":"2009","journal-title":"Blood"},{"issue":"12","key":"key\n\t\t\t\t20170520213912_CIT0029","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.2012.45.3266","article-title":"Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95","volume":"31","author":"Dorffel","year":"2013","journal-title":"J Clin Oncol"},{"issue":"26","key":"key\n\t\t\t\t20170520213912_CIT0030","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1200\/JCO.2011.41.1819","article-title":"Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin\u2019s lymphoma--a report from the Children\u2019s Oncology Group","volume":"30","author":"Wolden","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9","key":"key\n\t\t\t\t20170520213912_CIT0031","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.6004\/jnccn.2011.0088","article-title":"Evolution of radiation therapy within the German Hodgkin Study Group trials","volume":"9","author":"Eich","year":"2011","journal-title":"J Natl Compr Canc Netw"},{"issue":"13","key":"key\n\t\t\t\t20170520213912_CIT0032","first-page":"10","article-title":"Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)","author":"Specht","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"key\n\t\t\t\t20170520213912_CIT0033","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ajh.23348","article-title":"Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management","volume":"87","author":"Ansell","year":"2012","journal-title":"Am J Hematol"},{"issue":"27","key":"key\n\t\t\t\t20170520213912_CIT0034","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","article-title":"Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial","volume":"28","author":"Eich","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"key\n\t\t\t\t20170520213912_CIT0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"key\n\t\t\t\t20170520213912_CIT0036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2006.0024","article-title":"Late effects of treatment for Hodgkin lymphoma","volume":"4","author":"Friedman","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"key\n\t\t\t\t20170520213912_CIT0037","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood"},{"issue":"11","key":"key\n\t\t\t\t20170520213912_CIT0038","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood-2012-02-409821","article-title":"Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks","volume":"120","author":"Yeh","year":"2012","journal-title":"Blood"},{"issue":"1","key":"key\n\t\t\t\t20170520213912_CIT0039","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2008.04.067","article-title":"Subsequent malignancies in children treated for Hodgkin\u2019s disease: associations with gender and radiation dose","volume":"72","author":"Constine","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20170520213912_CIT0040","author":"National Cancer Institute"},{"issue":"18","key":"key\n\t\t\t\t20170520213912_CIT0041","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.ejca.2003.09.013","article-title":"The management of cancer in the older adolescent","volume":"39","author":"Albritton","year":"2003","journal-title":"Eur J Cancer"},{"issue":"18","key":"key\n\t\t\t\t20170520213912_CIT0042","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.ejca.2003.09.005","article-title":"Who should be treating adolescents and young adults with acute lymphoblastic leukaemia?","volume":"39","author":"Jeha","year":"2003","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20170520213912_CIT0043","doi-asserted-by":"crossref","first-page":"824691","DOI":"10.1155\/2010\/824691","article-title":"Socioeconomic Impacts on Survival Differ by Race\/Ethnicity among Adolescents and Young Adults with Non-Hodgkin\u2019s Lymphoma","volume":"2010","author":"Kent","year":"2010","journal-title":"J Cancer Epidemiol"},{"issue":"4","key":"key\n\t\t\t\t20170520213912_CIT0044","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ijc.22417","article-title":"Socioeconomic inequality and short-term outcome in Hodgkin\u2019s lymphoma","volume":"120","author":"Soares","year":"2007","journal-title":"Int J Cancer"},{"issue":"24","key":"key\n\t\t\t\t20170520213912_CIT0045","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1002\/cncr.27684","article-title":"Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults","volume":"118","author":"Smith","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"key\n\t\t\t\t20170520213912_CIT0046","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1634\/theoncologist.11-6-590","article-title":"Cancer in 15- to 29-year-olds by primary site","volume":"11","author":"Bleyer","year":"2006","journal-title":"Oncologist"},{"issue":"29","key":"key\n\t\t\t\t20170520213912_CIT0047","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1200\/JCO.2006.07.6992","article-title":"Access to pediatric cancer care by age, race, and diagnosis, and outcomes of cancer treatment in pediatric and adolescent patients in the state of Georgia","volume":"25","author":"Howell","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"key\n\t\t\t\t20170520213912_CIT0048","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s10552-009-9382-3","article-title":"Disparities in survival after Hodgkin lymphoma: a population-based study","volume":"20","author":"Keegan","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"4","key":"key\n\t\t\t\t20170520213912_CIT0049","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/15513815.2012.721480","article-title":"Ethnicity and age disparities in Ewing sarcoma outcome","volume":"32","author":"Koohbanani","year":"2013","journal-title":"Fetal Pediatr Pathol"},{"issue":"8","key":"key\n\t\t\t\t20170520213912_CIT0050","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/cncr.24937","article-title":"Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry","volume":"116","author":"Lee","year":"2010","journal-title":"Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/106\/11\/dju300\/17313338\/dju300.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T17:34:33Z","timestamp":1598376873000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/dju300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,10,9]]},"published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dju300","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,9]]}}}